You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 65 No. 2, February 1952 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (46)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

CORTISONE ACETATE IN SKIN DISEASE

Local Effect in the Skin from Topical Application and Local Injection

LEON GOLDMAN, M.D.; LIEUTENANT COLONEL ROBERT G. THOMPSON; CAPTAIN E. RANDOLPH TRICE

AMA Arch Derm Syphilol. 1952;65(2):177-186.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

CORTISONE acetate (cortone®) has been found to have a local effect in various diseases of the eye, especially those of an inflammatory or exudative nature.1 In ophthalmology, suspensions of cortisone have been used locally as drops and by subconjunctival injection and ointment. In some instances it was necessary to dilute the suspension 1:4 because of local irritation. Special ophthalmic preparations of cortisone with buffered solutions are available. However, topical application does not have any effect on exudation in the vitreous body according to Woods.2 After injection into the anterior chamber Woods1h has reported a heavy flocculent mass disappearing within 24 to 48 hours. After subconjunctival injection remnants can be seen for several weeks. The advantages of local cortisone therapy are obvious. These include the utilization of smaller quantities of medication, avoidance of systemic side-effects, therapy of ambulatory patients, and therapy of aged or debilitated patients. In one . . . [Full Text PDF of this Article]


Author Affiliations

CINCINNATI; MEDICAL CORPS, ARMY OF THE UNITED STATES

From the Department of Dermatology and Syphilology of the University of Cincinnati College of Medicine and the University of Cincinnati, and the Dermatology and Syphilology Section, Walter Reed Army Hospital.


Footnotes

Hypospray® jet injection instruments were furnished by J. M. McKibbin, R. P. Scherer Corporation, Detroit.

Cortisone acetate (cortone®), water-soluble ester of cortisone, and compound F (17-hydroxycorticosterone acetate) were furnished by Dr. J. M. Carlisle, Merck & Company, Inc. Rahway, N. J.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1952 American Medical Association. All Rights Reserved.